Centro Cardiologico Monzino S.p.A.

At Centro Cardiologico Monzino S.p.A. in Milan, the strongest research focus is on cardiovascular diseases, with trials spanning atherosclerotic cardiovascular disease, heart failure, myocardial infarction, and complex inherited or inflammatory heart conditions. Many studies aim to test new treatments, reduce major cardiovascular events, and slow disease progression in people at high risk.

• Prevention of heart attacks, stroke, and other major cardiovascular events in high-risk patients
• New approaches for heart failure, including preserved, reduced, and mildly reduced ejection fraction
• Research on coronary artery disease, plaque progression, and lipid-related risk
• Studies in cardiomyopathies, aortic valve stenosis, and inflammatory heart disease

The site also investigates treatment strategies for conditions such as atrial fibrillation, hypertrophic cardiomyopathy, and transthyretin amyloid cardiomyopathy, reflecting a broad effort to improve both outcomes and long-term care.

Research in nutritional and metabolic diseases is centered on obesity, overweight, type 2 diabetes mellitus, and severe lipid disorders such as hypercholesterolemia and homozygous familial hypercholesterolemia. These trials are designed to evaluate therapies that may improve weight control, metabolic health, and cardiovascular risk at the same time.

• Weight-management studies in people with obesity or overweight
• Trials in type 2 diabetes focused on cardiovascular protection
• Lipid-lowering research for ASCVD, elevated Lp(a), and familial hypercholesterolemia
• Studies combining metabolic and heart outcomes to assess overall treatment benefit

Several projects also explore whether newer therapies can lower plaque burden, improve blood lipids, and reduce the risk of future cardiovascular complications in patients with metabolic disease.

The respiratory tract diseases portfolio is smaller but important, with studies in acute respiratory distress syndrome and pulmonary hypertension linked to heart failure. This work focuses on improving recovery, easing symptoms, and finding better supportive or disease-modifying treatments.

• ARDS research aimed at improving outcomes in severe lung inflammation and respiratory failure
• Pulmonary hypertension studies in patients with heart failure and breathing limitation
• Trials assessing whether new therapies can improve exercise capacity and daily function
• Supportive care research in critically ill patients with serious respiratory complications

At this site, respiratory research is closely connected to cardiac care, especially where breathing disorders overlap with heart failure and reduced physical performance.